ImmunoIVD AB
ImmunoIVD develops innovative, reliable qPCR assays for newborn screening.
Oversigt
- 20–49
- Medarbejdere
- 50–100mio SEK
- Omsætning
- 2015
- Grundlagt
Nøglebeslutningstagere
Erna Domsgen
Chief Executive Officer
Beskrivelse
ImmunoIVD is a Swedish company established in 2015, specializing in the development of innovative and reliable newborn screening assays. Their core mission is to simplify newborn screening by providing accessible, high-quality diagnostic products for early detection. They manufacture CE IVD marked S...